GlassScriptWallstent Rp Endoprosthesis
Payments companies reported to CMS as associated with Wallstent Rp Endoprosthesis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Wallstent Rp Endoprosthesis, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Wallstent Rp Endoprosthesis
These are the largest totals companies reported as associated with Wallstent Rp Endoprosthesis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Windsor Ting | New York, NY | Vascular Surgery | $236.54 |
| Meryl Logan | Temple, TX | Vascular Surgery | $70.21 |
| Nasim Hedayati | Sacramento, CA | Vascular Surgery | $70.21 |
| Joseph Dubose | Travis Afb, CA | Surgical Critical Care | $70.21 |
| Lili Sadri | Austin, TX | Vascular Surgery | $70.20 |
| James Li | Odessa, TX | Vascular Surgery | $68.08 |
| Kelly Mattimoe | Odessa, TX | Family | $68.08 |
| Daniela Flores | Odessa, TX | Nurse Practitioner | $68.07 |
| Anita Ramaiah | Scottsdale, AZ | Anesthesiology | $60.47 |
| Patricia Thorpe | Phoenix, AZ | Vascular & Interventional Radiology | $52.72 |
Prescribed Wallstent Rp Endoprosthesis?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.